Enovix Corp. (ENVX)
2.80
+0.02
(+0.72%)
USD |
NASDAQ |
Oct 02, 16:00
2.795
0.00 (0.00%)
After-Hours: 20:00
Enovix Research and Development Expense (Annual) : 110.33M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 110.33M |
| December 31, 2024 | 124.51M |
| December 31, 2023 | 88.39M |
| Date | Value |
|---|---|
| December 31, 2022 | 58.05M |
| December 31, 2021 | 37.85M |
| December 31, 2020 | 14.44M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Eos Energy Enterprises, Inc. | 28.54M |
| Amprius Technologies, Inc. | 9.43M |
| ESS Tech, Inc. | 6.59M |
| Fluence Energy, Inc. | 86.22M |
| Ultralife Corp. | 9.003M |